What is the incidence of type 1 diabetes (T1D) in children in the United States?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Incidence of Type 1 Diabetes in the United States

Type 1 diabetes incidence in the United States is increasing at a rate of approximately 1.9% annually in youth (ages 0-19), with current estimates showing 22.2 cases per 100,000 person-years as of 2017-2018. The annual number of new type 1 diabetes cases in the United States is estimated at 64,000 annually (27,000 cases in youth and 37,000 cases in adults) 1.

Epidemiology of Type 1 Diabetes

Incidence by Age

  • Highest incidence occurs in youth aged 10-14 years (45.5 cases/100,000 person-years) 1
  • Peak age at diagnosis is around 10 years for type 1 diabetes 2
  • While childhood onset is common, more new cases actually occur in adults (ages 20-64) than in youth 1

Gender Distribution

  • Male predominance is evident by age 10 and persists throughout adulthood
  • Male to female incidence rate ratio is 1.32 1

Geographic Variation

  • Significant regional differences exist within the United States
  • Highest increases in incidence have been observed in:
    • East South Central (3.8% annual increase)
    • Mountain divisions (3.1% annual increase)
    • East North Central (2.7% annual increase)
    • South Atlantic (2.4% annual increase)
    • West North Central divisions (2.4% annual increase) 1

Seasonal Patterns

  • Diagnosis of type 1 diabetes shows seasonal variation
  • Peak in new diagnoses occurs in January 2
  • Additional peaks in July and August have been observed 1

Trends in Type 1 Diabetes Incidence

The incidence of type 1 diabetes in youth has been steadily increasing:

  • 1.9% annual increase from 2001 to 2015 1
  • 1.4% annual increase from 2002 to 2012 3
  • 2.02% annual increase from 2002 to 2018 2

This increasing trend is more pronounced in racial and ethnic minority groups, with non-Hispanic Black and Hispanic children showing greater increases in incidence 2.

Risk Factors and Pathophysiology

Type 1 diabetes accounts for 5-10% of all diabetes cases and results from cellular-mediated autoimmune destruction of pancreatic β-cells 4. Key risk factors include:

  • Genetic predisposition (particularly HLA-DR/DQ alleles) 4
  • Family history (10-20% of newly diagnosed childhood cases have an affected first-degree relative) 5
  • Environmental triggers (though specific causative factors remain unclear) 5

Clinical Implications

The increasing incidence of type 1 diabetes in children will result in an expanding population of young adults at risk for early diabetes complications 2. This has significant implications for:

  • Healthcare resource allocation
  • Long-term monitoring for complications
  • Quality of life for affected individuals

Diagnostic Considerations

Distinguishing between type 1 and type 2 diabetes can be challenging, especially in overweight or obese adolescents. Key diagnostic approaches include:

  • Measurement of islet autoantibodies (GAD65, insulin, tyrosine phosphatases IA-2 and IA-2b, and ZnT8) 4
  • Family history assessment
  • Plasma or urinary C-peptide concentrations 4

In patients with classic symptoms, diagnosis can be made with:

  • Random plasma glucose ≥200 mg/dL (11.1 mmol/L) with symptoms
  • Fasting plasma glucose ≥126 mg/dL (7 mmol/L)
  • 2-hour plasma glucose ≥200 mg/dL (11.1 mmol/L) during OGTT
  • A1C ≥6.5% 4

The rising incidence of type 1 diabetes, particularly in youth, highlights the importance of continued surveillance and research to identify driving factors and inform healthcare planning.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.